Brian Harel

ORCID: 0000-0003-2576-0789
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Memory and Neural Mechanisms
  • Dementia and Cognitive Impairment Research
  • Sleep and related disorders
  • Attention Deficit Hyperactivity Disorder
  • Multiple Sclerosis Research Studies
  • Sleep and Wakefulness Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Voice and Speech Disorders
  • Neural and Behavioral Psychology Studies
  • Posttraumatic Stress Disorder Research
  • Parkinson's Disease Mechanisms and Treatments
  • Stuttering Research and Treatment
  • Cancer-related cognitive impairment studies
  • Treatment of Major Depression
  • Emotion and Mood Recognition
  • Schizophrenia research and treatment
  • Childhood Cancer Survivors' Quality of Life
  • Glioma Diagnosis and Treatment
  • Functional Brain Connectivity Studies
  • Psychosomatic Disorders and Their Treatments
  • Traumatic Brain Injury Research
  • Dysphagia Assessment and Management
  • Delphi Technique in Research
  • Liver Disease and Transplantation
  • Mental Health Research Topics

Takeda (United States)
2018-2025

Takeda (France)
2021

Pfizer (United States)
2004-2020

Yale University
2013-2017

Connecticut Sea Grant
2011-2017

RMIT University
2017

Imperial College London
2017

University of Iowa Hospitals and Clinics
2006

University of Connecticut
2001-2004

Jewish Community Centre Association of North America
1978

Objective: To determine whether subjective memory complaints (SMCs) are associated with performance on objective cognitive measures and psychological factors in healthy, community-dwelling older adults. Method: The cohort was composed of adults, 65 years no clinical evidence impairment (n = 125). Participants were administered: CogState computerized neurocognitive battery, Prospective Retrospective Memory Questionnaire, personality meaning-in-life measures. Results: SMCs poorer executive...

10.1177/1533317513504817 article EN American Journal of Alzheimer s Disease & Other Dementias® 2013-12-01

Posttraumatic stress disorder (PTSD) has been linked to cognitive decline, but research in women is generally lacking. We examined whether trauma and elevated PTSD symptoms were associated with worse function middle-aged civilian women. A secondary objective was investigate the possible role of depression relation function.The sample comprised 14,029 Nurses' Health Study II. Lifetime exposure, lifetime symptoms, past-week depressive measured 2008. Cognitive 2014-2016 using Cogstate Brief...

10.1002/da.22600 article EN Depression and Anxiety 2017-01-10

Abstract Introduction The purpose of this study is to compare online neuropsychological test performance older adults across self‐reported diagnoses being cognitively normal, mild cognitive impairment, and dementia due Alzheimer's disease determine the association memory concerns family history on performance. Methods Participants completed Cogstate Brief Battery unsupervised at home. Results Data from 6463 participants over age 55 years were analyzed. Adults with diagnosis impairment...

10.1016/j.dadm.2018.05.005 article EN cc-by-nc-nd Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2018-01-01

Objective: Repeat cognitive assessment comparing post-injury performance to a pre-injury baseline is common in concussion management. Although tests are typically administered clinical settings, may be conducted individually with one-on-one supervision, group or without supervision. The extent which these different test settings affect not well understood. To assess if on the Cogstate Brief Battery (CBB) differs across completed supervision were compared those taken either but Method: A...

10.1080/13854046.2015.1054437 article EN The Clinical Neuropsychologist 2015-05-19

Treating patient populations with significant psychiatric and neurocognitive symptomatology can present a unique clinical dilemma: progress in psychotherapy be significantly fettered by cognitive deficits, whereas rehabilitation efforts ineffective because of overlay. Application mindfulness-based interventions to address either or symptoms isolation appears efficacious many contexts; however, it remains unclear whether this type intervention might help simultaneous symptomatology. In...

10.7205/milmed-d-14-00581 article EN Military Medicine 2015-08-31

To better understand the nature and rate of cognitive change across adolescence, Cogstate Brief Battery (CBB) was utilized to assess psychomotor function, attention, working memory, visual learning in individuals aged 10-18 years old. Since all CBB tasks have equivalent perceptual, motor, linguistic demands as well being appropriate for both children adults, this approach allowed direct across-age comparison multiple domains. Exponential decreases reaction time linear increases accuracy were...

10.3389/fpsyg.2015.00704 article EN cc-by Frontiers in Psychology 2015-05-27

Background: Moderately vigorous physical activity (MVPA) provides a protective affect against cognitive decline and cardiovascular risk factors. Less is known about sedentary pastimes or non exercise (NEPA) performance. Method: 125 healthy adults 65 older with no clinical evidence of impairment were enrolled. The CogState computerized neurocognitive battery was administered. Leisure activities measured using the Community Health Activity Program for Seniors (CHAMPS). Results: Sedentary...

10.1177/1533317514545615 article EN American Journal of Alzheimer s Disease & Other Dementias® 2014-08-05

Neurosciences clinical trials continue to have notoriously high failure rates. Appropriate outcomes selection in early is key maximizing the likelihood of identifying new treatments psychiatry and neurology. The field lacks good standards for designing outcome strategies, therefore Outcomes Research Group was formed develop promote practices selection. This article describes first published guidance on standardization process neuroscience. A minimal step defined starting as possible,...

10.1016/j.euroneuro.2024.02.009 article EN cc-by-nc-nd European Neuropsychopharmacology 2024-04-04

Visual spatial learning is impaired in mild cognitive impairment (MCI) although the nature of this not clear. This study investigated and magnitude errors made by adults with amnestic MCI (aMCI) when pattern-location paired associations a continuous manner.Visual associate was measured using Continuous Paired Associate Learning (CPAL) task which 30 who met clinical criteria for aMCI matched controls were required to learn set between patterns locations across increasing memory loads (two,...

10.1037/a0024237 article EN Neuropsychology 2011-07-05

Abstract Cognitive decline is a major health concern and identification of genes that may serve as drug targets to slow important adequately support an aging population. Whilst genetic studies cross-sectional cognition have been carried out, cognitive change less well-understood. Here, using data from the TOMMORROW trial, we investigate associations with in cognitively normal older cohort. We conducted genome-wide association study trajectories repeated measures (using generalised estimating...

10.1038/s41398-023-02726-6 article EN cc-by Translational Psychiatry 2024-01-18

Abstract People with narcolepsy type 1 (NT1), 2 (NT2), and idiopathic hypersomnia (IH) often report cognitive impairment which can be quite burdensome but is rarely evaluated in routine clinical practice. In this systematic review meta-analysis, we assessed the nature magnitude of NT1, NT2, IH studies conducted from January 2000 to October 2022. We classified tests assessing memory, executive function, attention by domain. Between-group differences were analyzed as standardized mean (Cohen’s...

10.1093/sleepadvances/zpae043 article EN cc-by SLEEP Advances 2024-01-01

Background: PF-06412562 is an orally bioavailable, selective dopamine D1/D5 receptor partial agonist with a non-catechol structure under evaluation for treatment of cognitive impairment in schizophrenia. Aims: This randomized, double-blind, placebo-controlled, parallel-group, Phase 1b study examined the pharmacokinetics and pharmacodynamics three doses (3 mg, 9 45 mg twice daily) over 15 days patients schizophrenia receiving antipsychotics. Methods: Primary endpoints included adjunctive...

10.1177/0269881119855302 article EN Journal of Psychopharmacology 2019-07-02

Morale and Life Satisfaction measures were used as independent variables to compare elderly subjects' degrees of participation in an organized leisure program. In examining the first 6 months membership a community center 109 non-institutionalized aged, it was found that 42% became regular users age-segregated older adult program, 36% erratic users, 21% non-users. Upon comparing their morale life satisfaction ratings, low scores on these two be significantly related use services, while high...

10.1093/geront/12.4.368 article EN The Gerontologist 1972-12-01
Coming Soon ...